Lakhvir K. Assi

935 total citations
17 papers, 737 citations indexed

About

Lakhvir K. Assi is a scholar working on Molecular Biology, Immunology and Nephrology. According to data from OpenAlex, Lakhvir K. Assi has authored 17 papers receiving a total of 737 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 5 papers in Immunology and 3 papers in Nephrology. Recurrent topics in Lakhvir K. Assi's work include Cell death mechanisms and regulation (5 papers), Platelet Disorders and Treatments (3 papers) and Immune Response and Inflammation (3 papers). Lakhvir K. Assi is often cited by papers focused on Cell death mechanisms and regulation (5 papers), Platelet Disorders and Treatments (3 papers) and Immune Response and Inflammation (3 papers). Lakhvir K. Assi collaborates with scholars based in United Kingdom, New Zealand and Germany. Lakhvir K. Assi's co-authors include Janet M. Lord, Dagmar Scheel‐Toellner, Paul R. Webb, Rachel Craddock, M Salmon, Mike Salmon, Helen M. McGettrick, Keqing Wang, Erich Gulbins and Louise E. Clough and has published in prestigious journals such as Blood, PLoS ONE and Diabetes Care.

In The Last Decade

Lakhvir K. Assi

17 papers receiving 728 citations

Peers

Lakhvir K. Assi

IMMUN

RHEUM

PFM

PHYSI

Aysın Tulunay Virlan Türkiye

Takaaki Fukuda Japan

Anquan Liu Sweden

Huifang Zhou China

Ning Ma China

D. Chimenti Italy

Rochelle L. Argentieri United States

Nobuki Maki Japan

Arthur Lau Canada

Aysın Tulunay Virlan Türkiye

Lakhvir K. Assi

138 ×0.4

287 ×0.9

IMMUN

128 ×1.5

RHEUM

55 ×0.7

PFM

123 ×1.7

PHYSI

Citations per year, relative to Lakhvir K. Assi Lakhvir K. Assi (= 1×) peers Aysın Tulunay Virlan

Countries citing papers authored by Lakhvir K. Assi

Since Specialization

Citations

This map shows the geographic impact of Lakhvir K. Assi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lakhvir K. Assi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lakhvir K. Assi more than expected).

Fields of papers citing papers by Lakhvir K. Assi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lakhvir K. Assi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lakhvir K. Assi. The network helps show where Lakhvir K. Assi may publish in the future.

Co-authorship network of co-authors of Lakhvir K. Assi

This figure shows the co-authorship network connecting the top 25 collaborators of Lakhvir K. Assi. A scholar is included among the top collaborators of Lakhvir K. Assi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lakhvir K. Assi. Lakhvir K. Assi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Ritchie, James, et al.. (2015). Association of Serum Ig Free Light Chains with Mortality and ESRD among Patients with Nondialysis-Dependent CKD. Clinical Journal of the American Society of Nephrology. 10(5). 740–749. 18 indexed citations

Assi, Lakhvir K., Natasha J. McIntyre, Simon Fraser, et al.. (2015). The Association between Polyclonal Combined Serum Free Light Chain Concentration and Mortality in Individuals with Early Chronic Kidney Disease. PLoS ONE. 10(7). e0129980–e0129980. 11 indexed citations

Teng, Mabel, Sarah Pirrie, Douglas G. Ward, et al.. (2014). Diagnostic and mechanistic implications of serum free light chains, albumin and alpha-fetoprotein in hepatocellular carcinoma. British Journal of Cancer. 110(9). 2277–2282. 8 indexed citations

Hassan‐Smith, Ghaniah, Lakhvir K. Assi, Jeff Faint, et al.. (2014). High sensitivity and specificity of elevated cerebrospinal fluid kappa free light chains in suspected multiple sclerosis. Journal of Neuroimmunology. 276(1-2). 175–179. 61 indexed citations

Basu, Supratik, David Sutton, Philip A. Kalra, et al.. (2014). Quantification of polyclonal free light chains in clinical samples using a single turbidimetric immunoassay. Clinical Chemistry and Laboratory Medicine (CCLM). 0(0). 1605–13. 5 indexed citations

Bellary, Srikanth, Lakhvir K. Assi, Colin A. Hutchison, et al.. (2014). Elevated Serum Free Light Chains Predict Cardiovascular Events in Type 2 Diabetes. Diabetes Care. 37(7). 2028–2030. 16 indexed citations

Assi, Lakhvir K., Mark Jesky, Stephanie Stringer, et al.. (2013). A simple scoring algorithm using serum free light chains for the risk assessment of progression of chronic kidney disease. 4. 1 indexed citations

Assi, Lakhvir K., Charles J. Ferro, Anthony Barnett, et al.. (2013). The relationship between high‐sensitivity CRP and polyclonal Free Light Chains as markers of inflammation in chronic disease. International Journal of Laboratory Hematology. 36(4). 415–424. 27 indexed citations

Assi, Lakhvir K., et al.. (2012). Elevated, combined serum free light chain levels and increased mortality: a 5-year follow-up, UK study. Journal of Clinical Pathology. 65(11). 1036–1042. 35 indexed citations

10.

Assi, Lakhvir K., et al.. (2010). 1139 ABNORMALLY ELEVATED SERUM FREE LIGHT CHAINS IN PATIENTS WITH LIVER DISEASE. Journal of Hepatology. 52. S440–S441. 3 indexed citations

11.

Scheel‐Toellner, Dagmar, Karim Raza, Lakhvir K. Assi, et al.. (2007). Differential regulation of nuclear and mitochondrial Bcl-2 in T cell apoptosis. APOPTOSIS. 13(1). 109–117. 7 indexed citations

12.

Assi, Lakhvir K., See Heng Wong, Andreas Ludwig, et al.. (2007). Tumor necrosis factor α activates release of B lymphocyte stimulator by neutrophils infiltrating the rheumatoid joint. Arthritis & Rheumatism. 56(6). 1776–1786. 60 indexed citations

13.

Raza, Karim, Dagmar Scheel‐Toellner, Darrell Pilling, et al.. (2006). Synovial fluid leukocyte apoptosis is inhibited in patients with very early rheumatoid arthritis. Arthritis Research & Therapy. 8(4). R120–R120. 72 indexed citations

14.

Hampson, Peter, Hema Chahal, Farhat L. Khanim, et al.. (2005). PEP005, a selective small-molecule activator of protein kinase C, has potent antileukemic activity mediated via the delta isoform of PKC. Blood. 106(4). 1362–1368. 108 indexed citations

15.

Scheel‐Toellner, Dagmar, Lakhvir K. Assi, Paul R. Webb, et al.. (2004). Clustering of death receptors in lipid rafts initiates neutrophil spontaneous apoptosis. Biochemical Society Transactions. 32(5). 679–681. 75 indexed citations

16.

Scheel‐Toellner, Dagmar, Paul R. Webb, See Heng Wong, et al.. (2004). Early events in spontaneous neutrophil apoptosis. Biochemical Society Transactions. 32(3). 461–464. 63 indexed citations

17.

Scheel‐Toellner, Dagmar, Keqing Wang, Rachel Craddock, et al.. (2004). Reactive oxygen species limit neutrophil life span by activating death receptor signaling. Blood. 104(8). 2557–2564. 167 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact